BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FOXP1
,
cell-cell adhesion
,
Obesity
,
Adipose tissue
,
Alcohol
,
Fenofibrate
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
v d) j recombination
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Livers of chronic hepatitis C patients treated with PegIntron (pegIFNα-2b) or Pegasys (pegIFNα-2a)
Neuronal cortical cultures treated with HIV recombinant TAT (1–86), DDX3 inhibitor RK33 & cocaine
Explore Curated Studies Results
Literature
Most Relevant Literature
The role of CTCF in regulating V(D)J recombination.
RAG and HMGB1 create a large bend in the 23RSS in the V(D)J recombination synaptic complexes.
Functional redundancy between repair factor XLF and damage response mediator 53BP1 in V(D)J recombin…
Cooperative recruitment of HMGB1 during V(D)J recombination through interactions with RAG1 and DNA.
Functional redundancy between the XLF and DNA-PKcs DNA repair factors in V(D)J recombination and non…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioe…
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage …
Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients
Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Init…
Immune Responses in Patients Treated With Raltegravir
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ